FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1155981486> ?p ?o ?g. }

• W1155981486 endingPage "29" @default.
• W1155981486 startingPage "22" @default.
• W1155981486 abstract "Objectives. We examined the level of persistence (remaining on therapy) and compliance (taking the medication according to directions) and its impact on the effectiveness of therapy in patients with postmenopausal osteoporosis (PMO) treating with combination medication containing 70 mg alendronic acide and 2800 IU colecalciferol - Fosavance under the supervision of medical practitioners. Material and methods. The trial was performed in the form of 2-year prospective observational multicenter study that included 373 patients with PMO aged 40-88 years, initiated therapy with Fosavance under the supervision of 20 physicians had their medical practice in Moscow (18) or Moscow region (2). Patient compliance and persistence with therapy assessed every 6 months for 2 years, the effectiveness of treatment evaluated in 2 years on the dynamics of bone mineral density (BMD) and indicators of quality of life (QOL) by the SF-36 scale. Results. 70.2% of recruited in the study PMO patients prematurely stopped therapy with Fosavance, including 41% - in the first 6 months. Among the patients who dropped out, 42.7% were lost to follow by medical practitioners, 28.6% switched to another drug therapy, 19.1% had no money to buy medication. 22.5% from 111 women who continued treatment after 2 years were non-compliant due to the high cost of therapy (52%), optionality with the purchase of the drug at the pharmacy (28%) or taking pills (16%), or lack of medication in the pharmacy (4%). There were no statistically significant differences in BMD change in compliant (CP) and non-compliant patients (NCP) in lumbar spine, trochanter and total proximal femur in 2 years. But the increase in femoral neck BMD was higher in CP vs. NCP (Δ=1.97% [-1.41; 13.3] and Δ=-2.03 [-10.4 5.20], p=0.0267). CP had greater increase in QOL by SF-36 scoring at role-physical functioning (Δ=5 points [0; 25] at CP vs. Δ=0 points [-50; 0] at NCP, p=0.0195), role-emotional functioning (Δ=50 points [0; 84] and Δ=0 points [-100; 0] respectively, p=0.0001) and social functioning (Δ=13 points [-13; 25] and Δ=-13 points [-25; 0] respectively, p=0.0048). Conclusions. Low adherence to Fosavance negative impact on the effectiveness of treatment PMO and QOL. At the initiation of therapy it's requires close interaction between the doctor and the patient, maintaining patients on regular treatment motivation and selection of the drug taking into account convenience of the reception." @default.
• W1155981486 created "2016-06-24" @default.
• W1155981486 creator A5000626028 @default.
• W1155981486 creator A5006547541 @default.
• W1155981486 creator A5009911661 @default.
• W1155981486 creator A5073774483 @default.
• W1155981486 date "2014-08-15" @default.
• W1155981486 modified "2023-10-14" @default.
• W1155981486 title "The adherence of postmenopausal osteoporosis patients to therapy with combination medication contains alendronic acid and colecalciferol and its impact on the effectiveness of treatment" @default.
• W1155981486 cites W1941723515 @default.
• W1155981486 cites W1963899208 @default.
• W1155981486 cites W1990311075 @default.
• W1155981486 cites W1996683346 @default.
• W1155981486 cites W2007965843 @default.
• W1155981486 cites W2013932243 @default.
• W1155981486 cites W2048541373 @default.
• W1155981486 cites W2073036490 @default.
• W1155981486 cites W2091930575 @default.
• W1155981486 cites W2107490395 @default.
• W1155981486 cites W2130463831 @default.
• W1155981486 cites W2145230424 @default.
• W1155981486 cites W2151845115 @default.
• W1155981486 cites W2153009489 @default.
• W1155981486 doi "https://doi.org/10.14341/probl201460422-29" @default.
• W1155981486 hasPublicationYear "2014" @default.
• W1155981486 type Work @default.
• W1155981486 sameAs 1155981486 @default.
• W1155981486 citedByCount "3" @default.
• W1155981486 countsByYear W11559814862021 @default.
• W1155981486 countsByYear W11559814862023 @default.
• W1155981486 crossrefType "journal-article" @default.
• W1155981486 hasAuthorship W1155981486A5000626028 @default.
• W1155981486 hasAuthorship W1155981486A5006547541 @default.
• W1155981486 hasAuthorship W1155981486A5009911661 @default.
• W1155981486 hasAuthorship W1155981486A5073774483 @default.
• W1155981486 hasBestOaLocation W11559814861 @default.
• W1155981486 hasConcept C104863432 @default.
• W1155981486 hasConcept C126322002 @default.
• W1155981486 hasConcept C159110408 @default.
• W1155981486 hasConcept C1862650 @default.
• W1155981486 hasConcept C23131810 @default.
• W1155981486 hasConcept C2776541429 @default.
• W1155981486 hasConcept C2776886416 @default.
• W1155981486 hasConcept C2776999253 @default.
• W1155981486 hasConcept C2779457091 @default.
• W1155981486 hasConcept C2779809032 @default.
• W1155981486 hasConcept C2779951463 @default.
• W1155981486 hasConcept C2780670349 @default.
• W1155981486 hasConcept C500440147 @default.
• W1155981486 hasConcept C512399662 @default.
• W1155981486 hasConcept C71924100 @default.
• W1155981486 hasConcept C81603835 @default.
• W1155981486 hasConcept C98274493 @default.
• W1155981486 hasConceptScore W1155981486C104863432 @default.
• W1155981486 hasConceptScore W1155981486C126322002 @default.
• W1155981486 hasConceptScore W1155981486C159110408 @default.
• W1155981486 hasConceptScore W1155981486C1862650 @default.
• W1155981486 hasConceptScore W1155981486C23131810 @default.
• W1155981486 hasConceptScore W1155981486C2776541429 @default.
• W1155981486 hasConceptScore W1155981486C2776886416 @default.
• W1155981486 hasConceptScore W1155981486C2776999253 @default.
• W1155981486 hasConceptScore W1155981486C2779457091 @default.
• W1155981486 hasConceptScore W1155981486C2779809032 @default.
• W1155981486 hasConceptScore W1155981486C2779951463 @default.
• W1155981486 hasConceptScore W1155981486C2780670349 @default.
• W1155981486 hasConceptScore W1155981486C500440147 @default.
• W1155981486 hasConceptScore W1155981486C512399662 @default.
• W1155981486 hasConceptScore W1155981486C71924100 @default.
• W1155981486 hasConceptScore W1155981486C81603835 @default.
• W1155981486 hasConceptScore W1155981486C98274493 @default.
• W1155981486 hasIssue "4" @default.
• W1155981486 hasLocation W11559814861 @default.
• W1155981486 hasOpenAccess W1155981486 @default.
• W1155981486 hasPrimaryLocation W11559814861 @default.
• W1155981486 hasRelatedWork W1900305254 @default.
• W1155981486 hasRelatedWork W1957232404 @default.
• W1155981486 hasRelatedWork W1965974344 @default.
• W1155981486 hasRelatedWork W1987794022 @default.
• W1155981486 hasRelatedWork W2337574971 @default.
• W1155981486 hasRelatedWork W2358157500 @default.
• W1155981486 hasRelatedWork W2417221992 @default.
• W1155981486 hasRelatedWork W2595498604 @default.
• W1155981486 hasRelatedWork W4298369519 @default.
• W1155981486 hasRelatedWork W4379377091 @default.
• W1155981486 hasVolume "60" @default.
• W1155981486 isParatext "false" @default.
• W1155981486 isRetracted "false" @default.
• W1155981486 magId "1155981486" @default.
• W1155981486 workType "article" @default.